Purdue continues OxyContin patent battle

10-10-2017

Purdue continues OxyContin patent battle

Savushkin / iStockphoto.com

Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin (oxycodone).


Purdue, Collegium; patent; patent infringement; NDA; New Drug Application; US District Court for the District of Massachusetts; Xtampza; OxyContin; oxycod

LSIPR